These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9009311)

  • 1. Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen.
    Mielcarek N; Cornette J; Schacht AM; Pierce RJ; Locht C; Capron A; Riveau G
    Infect Immun; 1997 Feb; 65(2):544-50. PubMed ID: 9009311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis.
    Renauld-Mongénie G; Mielcarek N; Cornette J; Schacht AM; Capron A; Riveau G; Locht C
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7944-9. PubMed ID: 8755582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis.
    Mielcarek N; Riveau G; Remoué F; Antoine R; Capron A; Locht C
    Nat Biotechnol; 1998 May; 16(5):454-7. PubMed ID: 9592394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice.
    Sun JB; Mielcarek N; Lakew M; Grzych JM; Capron A; Holmgren J; Czerkinsky C
    J Immunol; 1999 Jul; 163(2):1045-52. PubMed ID: 10395703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection.
    Da'Dara AA; Skelly PJ; Walker CM; Harn DA
    Parasite Immunol; 2003; 25(8-9):429-37. PubMed ID: 14651590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni.
    Boulanger D; Reid GD; Sturrock RF; Wolowczuk I; Balloul JM; Grezel D; Pierce RJ; Otieno MF; Guerret S; Grimaud JA
    Parasite Immunol; 1991 Sep; 13(5):473-90. PubMed ID: 1956696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice.
    Feunou PF; Kammoun H; Debrie AS; Locht C
    Vaccine; 2014 Jul; 32(34):4281-8. PubMed ID: 24950361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated Bordetella pertussis BPZE1 as a live vehicle for heterologous vaccine antigens delivery through the nasal route.
    Li R; Lim A; Alonso S
    Bioeng Bugs; 2011; 2(6):315-9. PubMed ID: 22067832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genital antibody responses in mice after intranasal infection with an attenuated candidate vector strain of Bordetella pertussis.
    Mielcarek N; Nordström I; Menozzi FD; Locht C; Holmgren J
    Infect Immun; 2000 Feb; 68(2):485-91. PubMed ID: 10639408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing antibody responses elicited in mice immunized with recombinant bacillus Calmette-Guérin producing the Schistosoma mansoni glutathione S-transferase.
    Kremer L; Riveau G; Baulard A; Capron A; Locht C
    J Immunol; 1996 Jun; 156(11):4309-17. PubMed ID: 8666802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal vaccination against schistosomiasis using liposome-associated Sm 28 kDa glutathione S-transferase.
    Ivanoff N; Phillips N; Schacht AM; Heydari C; Capron A; Riveau G
    Vaccine; 1996 Aug; 14(12):1123-31. PubMed ID: 8911008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bordetella pertussis filamentous hemagglutinin enhances the immunogenicity of liposome-delivered antigen administered intranasally.
    Poulain-Godefroy O; Mielcarek N; Ivanoff N; Remoué F; Schacht AM; Phillips N; Locht C; Capron A; Riveau G
    Infect Immun; 1998 Apr; 66(4):1764-7. PubMed ID: 9529111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette-Guérin expressing glutathione S-transferase from Schistosoma haematobium.
    Kremer L; Dupré L; Riveau G; Capron A; Locht C
    Infect Immun; 1998 Dec; 66(12):5669-76. PubMed ID: 9826340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mucosally administered recombinant fusion protein vaccine against schistosomiasis protecting against immunopathology and infection.
    Lebens M; Sun JB; Sadeghi H; Bäckström M; Olsson I; Mielcarek N; Li BL; Capron A; Czerkinsky C; Holmgren J
    Vaccine; 2003 Jan; 21(5-6):514-20. PubMed ID: 12531651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intradermal immunization of rats with plasmid DNA encoding Schistosoma mansoni 28 kDa glutathione S-transferase.
    Dupré L; Poulain-Godefroy O; Ban E; Ivanoff N; Mekranfar M; Schacht AM; Capron A; Riveau G
    Parasite Immunol; 1997 Nov; 19(11):505-13. PubMed ID: 9427997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Wallerström G; Holmgren J
    Vaccine; 2001 May; 19(25-26):3360-8. PubMed ID: 11348699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal and systemic immunogenicity of a recombinant, non-ADP-ribosylating pertussis toxin: effects of formaldehyde treatment.
    Cropley I; Douce G; Roberts M; Chatfield S; Pizza M; Marsili I; Rappuoli R; Dougan G
    Vaccine; 1995 Dec; 13(17):1643-8. PubMed ID: 8719514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overproduction of SM28GST in a baculovirus expression vector and its use to evaluate the in vivo immune responses of mice vaccinated against Schistosoma mansoni with naked DNA encoding the SM28GST gene.
    Kayes SG; Shaneyfelt RC; Monteiro C; O'Brien JJ
    J Parasitol; 1998 Aug; 84(4):764-70. PubMed ID: 9714208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with recombinant adenovirus expressing multi-stage antigens of Toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes.
    Wang T; Yin H; Li Y; Zhao L; Sun X; Cong H
    Parasite; 2017; 24():12. PubMed ID: 28367800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.